BNGO stock

Bionano Genomics Inc (BNGO) support and resistance · rev $14.9M

Bionano Genomics Inc (BNGO) is a medical instruments & supplies company listed on US.

This page maps Bionano Genomics Inc (BNGO) support and resistance from cached range and valuation — not a live tape and not a trade alert.

Latest reported BNGO revenue for 2026-06-30 was $14.9M. Net income was -$15.7M. BNGO currently screens at market cap $13.4M.

BNGO currently screens at market cap $13.4M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.

A new BNGO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.

Not investment advice. Use the BNGO quote page for the session range and the stock page for the full model.

Not investment advice.

Full BNGO analysis